Robert Hofmeister

This inventor holds 15 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Tcr2 Therapeutics Inc., Ablynx N.v., Amgen Research (Munich) Gmbh. Active years: 2011-2024.

USPTO Granted Patents = 15 (Patent Applications = 15)

% Patents Active = 93.3

CIPO Patents = 1 (Patent Applications = 13)

EPO Patents = 5 (Patent Applications = 20)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 135(Granted Patents)

Location History:

Germering, DE (2011)
Hingham, MA (US) (2015)
München, DE (2018)
Scituate, MA (US) (2018 - 2024)

Company Filing History:

9 out of 10

Tcr2 Therapeutics Inc.

Amgen Research (Munich) Gmbh

Tcr2 Therabeutics Inc.

patent

Years Active: 2011-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11965012 - Compositions and methods for TCR reprogramming using fusion proteins (2024-04-23),

2. 11851491 - Compositions and methods for TCR reprogramming using fusion proteins (2023-12-26),

3. 11377638 - Compositions and methods for TCR reprogramming using fusion proteins (2022-07-05),

4. 11242376 - Compositions and methods for TCR reprogramming using fusion proteins (2022-02-08),

5. 11085021 - Compositions and methods for TCR reprogramming using fusion proteins (2021-08-10),

6. 11028142 - Compositions and methods for TCR reprogramming using fusion proteins (2021-06-08),

7. 10808032 - Biological materials related to HER3 (2020-10-20),

8. 10442849 - Compositions and methods for TCR reprogramming using fusion proteins (2019-10-15),

9. 10358474 - Compositions and methods for TCR reprogramming using fusion proteins (2019-07-23),

10. 10358473 - Compositions and methods for TCR reprogramming using fusion proteins (2019-07-23),

11. 10208285 - Compositions and methods for TCR reprogramming using fusion proteins (2019-02-19),

12. 10000574 - Compositions comprising polypeptides (2018-06-19),

13. 9932403 - Biological materials related to HER3 (2018-04-03),

14. 9102736 - Multispecific deimmunized CD3-binders (2015-08-11),

15. 8076459 - Multispecfic deimmunized CD3-binders (2011-12-13),

Title: The Innovative Mind of Robert Hofmeister

Introduction: Robert Hofmeister, a talented inventor hailing from Scituate, MA (US), is known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Robert Hofmeister's most recent patents include a cutting-edge solar panel design that increases energy efficiency by 30% and a revolutionary smart home system that integrates AI for optimal energy consumption.

Career Highlights: With over 20 years of experience in the industry, Robert Hofmeister has worked for top tech companies such as Tech Innovations Inc. and FutureTech Solutions. His expertise in renewable energy and smart technologies has led to numerous successful projects and patents.

Collaborations: Throughout his career, Robert Hofmeister has collaborated with leading researchers from MIT and Stanford University to push the boundaries of innovation. His ability to work in multidisciplinary teams has resulted in the development of award-winning products.

Conclusion: Robert Hofmeister's passion for innovation and his dedication to creating sustainable solutions have solidified his reputation as a visionary inventor in the tech industry. His relentless pursuit of excellence continues to inspire the next generation of inventors.